Home
Archive
Subscribe
The Renewal
Logo

Evidence standards


The clinic market is bigger than it has ever been

The clinic market is bigger than it has ever been

This issue does not have a clinical milestone at its centre. The important story this week is the conditions under which clinical results are evaluated, and who is watching them.

May 16, 2026

•

5 min read

Twenty years. Seven patients. A conditional approval.

Twenty years. Seven patients. A conditional approval.

In March, Japan approved the world's first iPSC-derived therapies. Here is what the evidence behind that approval actually looks like.

May 7, 2026

•

6 min read

What happens after the FDA says yes

What happens after the FDA says yes

The clinical trial worked. The FDA approved it. The patients who need it most are still waiting.

Apr 30, 2026

•

5 min read

The sales appointment that costs $20,000

The sales appointment that costs $20,000

The treatments were not FDA-approved. The patients were not told. The financing was arranged before they left the building.

Apr 21, 2026

•

5 min read

What an approved stem cell therapy actually looks like

What an approved stem cell therapy actually looks like

When regulation disappears..

Apr 14, 2026

•

8 min read

They treated a fetus with stem cells

They treated a fetus with stem cells

The result was specific, limited, and more important than most headlines made it sound.

Apr 7, 2026

•

8 min read

The stem cell basics nobody bothered to explain

The stem cell basics nobody bothered to explain

The word "stem cell" is doing a lot of work it was never designed to do.

Mar 30, 2026

•

8 min read

background

The Renewal

Real regenerative medicine news, explained honestly, in ten minutes a week.

NAVIGATE

STAY INFORMED

Join readers who want the truth about regenerative medicine.

© 2026 The Renewal.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv